Commercialization strategy for FormaCyte therapeutics: Type 1 diabetes patient insights and regulatory pathway analysis on US FDA's impact on other jurisdictions
This report aims to strengthen the commercialization strategy of FormaCyte, an innovative treatment for Type 1 Diabetes (T1D), by obtaining firsthand patient insights to bolster a patient-centered development and investigating the US’s regulatory impact for cell therapy on other jurisdictions to...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
Nanyang Technological University
2024
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/177416 |